Krebsmutationen: EGFR - das Protein, das die Krebswelt änderte.
The holiday season... With a considerable delay, we are now dedicating ourselves to the mutations that once turned #cancer therapy completely inside out: #EGFR mutations. Here we are mainly dealing with #lungcancer - although there are EGFR mutations in other types of cancer, especially glioblastoma, ACTIVATING mutations in the kinase domain are definitely a domain of NSCLC. Here we are no longer talking about individual active ingredients with a possible effect, but about generations of inhibitors - which shows how long we have been dealing with this (almost 20 years!). In the video, we always speak of the 3rd generation inhibitors in the plural, but all statements refer to osimertinib. The reason for this is that there are a number of similarly potent inhibitors of this generation, but none is better than osimertinib, which is why it is the only approved inhibitor of this generation in Europe and the USA. In this video, we have not yet dealt with resistance and subsequent therapy sequences. We'll take a closer look at that in another video. Unfortunately, the 15-minute upper limit could not be observed in this video - sorry, the target length remains the same for all videos of the "cancer mutations"... DISCLAIMER: In this video we use the word "molecule" very "freely" and chemically not quite correctly, e.g. T. as a synonym for "protein" - this is not intended, we apologize! If you or acquaintances are affected, we recommend contacting the following association: https://www.zielgenau.org - German association for patients with lung cancer and mutations that can be specifically treated. 00:00 Cancer mutations: EGFR 00:13 What is that actually? [SKIP INTRO] 07:23 Which types of cancer are affected? 08:23 Where does that come from? 09:52 How do you treat that? 19:18 What is the research doing? Our HER family video: • Rezeptoren bei Krebs Basics I: Die HER-Fam... Our video on receptor tyrosine kinases: • Was ist Krebs: Rezeptor-Tyrosin-Kinasen Our video on TP53 mutations: • Krebsmutationen: TP53 - Der Wächter des Ge... Our video on KRAS mutations: • Krebsmutationen: KRAS - The Ancient Enemy. __________________________ Created with: Microsoft PowerPoint, Ecamm Live Edited with: Final Cut Pro Music: "368" by Jobii [Epidemic Sound] Artwork: HealthCareSocialMedia

Cancer mutations: FGFR - the quartet!

Tyrosinkinase Inhibitoren & Co – Wie funktioniert die zielgerichtete Therapie?

Amivantamab, an antibody against EGFR-mutant non-small cell lung cancer, is reimbursed.

This Isn't Experimental: Vitamin K2 Kills Cancer — But Only at This Dose | Cancer Drug Designer

Understanding NSCLC Treatment When You Have an EGFR Mutation

Das Immunsystem bei Krebs und Krebstherapie | German Cancer Survivors Week 2026

Cancer mutations: ALK fusions - the sky is the limit.

How does chemotherapy work? A brief comparison to immunotherapy.

Conor Randall | They gave me 8 weeks to live now I'm cancer free

New Cancer Breakthrough Just Dropped… And Almost No One Is Talking About It #Chemotherapy

Lungenkrebs: So sieht die moderne Therapie bei einem Bronchialkarzinom aus! | Asklepios

Targeted therapies (in lung cancer) and the driver mutations

Before you Start or Refuse Cancer Therapy- WATCH THIS!

EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum

This Common Food Is Feeding Your Cancer Cells - Dr. William Li

Cancer and metabolism

Typische Krebssymptome: An welchen Anzeichen erkennen Sie frühzeitig Krebs? Darauf bitte achten

Ivermectin to Treat Cancer? Get the FACTS

Prostatakrebs: Neue Therapien, neue Perspektiven – Updates aus der Onkologie

